You are here
Unique Device Identification system: Communications and stakeholder engagement
Involving health professionals, healthcare organisations, consumers and industry in the development and implementation of the UDI system is critical to its success. The TGA will engage and consult with stakeholders to ensure that all perspectives, particularly those of consumers who use medical devices, are taken into account. Public reporting by the TGA will ensure that progress towards implementing the UDI system is transparent to all.
Consultations and forums
The TGA will continue to undertake a series of consultations to inform the planning and design of the Australian implementation. Each consultation will be designed to cover key topic areas that we will need to consider as we progress with our planning. The consultations will be listed on our consultation forecast page and promoted via relevant communication channels including social media.
The consultation process may include consultation papers, stakeholder workshops, discussions and working groups.
We will use our established forums including the Regulatory and Technical Consultative Forum for medical devices (RegTech Forum).
View the presentation slides or webinar recordings.
- Unique Device Identification - Webinar #5, 19 October 2021
A presentation on the role of a UDI Issuing Agency, including project update and Q&A
- Unique Device Identification - Webinar #4, 21 September 2021
The role of a UDI Issuing Agency
- Unique Device Identification - Webinar #3, 17 August 2021
Challenges and considerations on the journey to a global UDI system
- Unique Device Identification - Webinar #2, 20 July 2021
Further considerations for the Australian UDI, including global alignment, GMDN and data elements
- Unique Device Identification - Webinar #1, 15 June 2021
An introduction to the Australian Unique Device Identification system
Tell us what information you would like to see on the UDI 'hub' or suggest a webinar topic by emailing us at: email@example.com
Inform and involve
We will engage broadly across the healthcare system - from supply, procurement and distribution through to clinical use, patient use, registries and the use of device information for post-market analysis and research.
You can keep informed by: